SEC Form D filing
Akari Therapeutics Plc
Biotech · Series A · Regulation D 506(b) · FL · Filed June 3, 2026
Offering amount
$5.5M
Exemption
Reg D 506(b)
Issuer state
FL
Filing date
June 3, 2026
Signature date
June 3, 2026
CIK
0001541157
Summary
Auto-generatedbiotech company, $5.5M series-a raise in FL
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.